Stay updated on Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.

Latest updates to the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.4.3 in place of v3.4.2 as part of a minor site update.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse in government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding notice about potential delays and the NIH Clinical Center's status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedShow glossary option added; page metadata now includes 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and footer notices show 'No FEAR Act Data' and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedNo substantive changes to page content; revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedLocations section added, listing Texas as a site. Revision updated to v3.3.3.SummaryDifference0.5%

Stay in the know with updates to Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.